Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives.

MLA

Tomasello, Chiara, et al. “Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer: Clinical Management and Future Perspectives.” Critical Reviews in Oncology/Hematology, vol. 123, Mar. 2018, pp. 149–61. EBSCOhost, https://doi.org/10.1016/j.critrevonc.2018.01.013.

APA

Tomasello, C., Baldessari, C., Napolitano, M., Orsi, G., Grizzi, G., Bertolini, F., Barbieri, F., & Cascinu, S. (2018). Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives. Critical Reviews in Oncology/Hematology, 123, 149–161. https://doi.org/10.1016/j.critrevonc.2018.01.013

Chicago

Tomasello, Chiara, Cinzia Baldessari, Martina Napolitano, Giulia Orsi, Giulia Grizzi, Federica Bertolini, Fausto Barbieri, and Stefano Cascinu. 2018. “Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer: Clinical Management and Future Perspectives.” Critical Reviews in Oncology/Hematology 123 (March): 149–61. doi:10.1016/j.critrevonc.2018.01.013.